$1.30
+0.03 (+2.36%)
Open$1.26
Previous Close$1.27
Day High$1.30
Day Low$1.26
52W High$4.56
52W Low$1.16
Volume—
Avg Volume1.17M
Market Cap86.49M
P/E Ratio—
EPS$-0.67
SectorBiotechnology
Analyst Ratings
Strong Buy
14 analysts
Price Target
+731.5% upside
Current
$1.30
$1.30
Target
$10.81
$10.81
$7.63
$10.81 avg
$13.89
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 610.9K | 531.3K | 16.05M |
| Net Income | -47,087,867 | -36,854,578 | -3,462,613 |
| Profit Margin | -7,732.0% | -7,345.4% | -21.6% |
| EBITDA | -49,902,157 | -41,227,105 | -3,307,317 |
| Free Cash Flow | — | — | -2,137,974 |
| Rev Growth | +15.0% | +15.0% | +0.8% |
| Debt/Equity | — | — | 0.67 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $251.64 | -1.05% | 118.2 | 429.58B |
| AMGN | Amgen Inc | $362.12 | +0.44% | 24.8 | 193.10B |
| GILD | Gilead Sciences Inc | $126.34 | +0.01% | 17.1 | 157.21B |
| VRTX | Vertex Pharmaceuticals Inc | $496.73 | -0.58% | 28.1 | 121.87B |
| REGN | Regeneron Pharmaceuticals | $623.54 | -1.31% | 15.0 | 66.35B |
| ALNY | Alnylam Pharmaceuticals Inc | $301.03 | +2.56% | 69.3 | 39.97B |